Optimizing Lutetium 177–Anti–Carbonic Anhydrase IX Radioimmunotherapy in an Intraperitoneal Clear Cell Renal Cell Carcinoma Xenograft Model-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Optimizing Lutetium 177–Anti–Carbonic Anhydrase IX Radioimmunotherapy in an Intraperitoneal Clear Cell Renal Cell Carcinoma Xenograft Model

Published:2014-06 Issue:4 Volume:13 Page:7290.2014.00008
ISSN:1536-0121
Container-title:Molecular Imaging
language:en
Short-container-title:Mol Imaging

Author:

Muselaers Constantijn H.J.¹,Oosterwijk Egbert¹,Bos Desirée L.¹,Oyen Wim J.G.¹,Mulders Peter F.A.¹,Boerman Otto C.¹

Affiliation:

1. From the Departments of Urology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands

Publisher

SAGE Publications

Subject

Condensed Matter Physics,Radiology, Nuclear Medicine and imaging,Biomedical Engineering,Molecular Medicine,Biotechnology

Link

http://journals.sagepub.com/doi/pdf/10.2310/7290.2014.00008

Reference20 articles.

1. Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma

2. Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial

3. Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

4. Phase III Trial of Bevacizumab Plus Interferon Alfa Versus Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: Final Results of CALGB 90206

5. Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical Characterization of DPI-4452: A⁶⁸Ga/¹⁷⁷Lu Theranostic Ligand for Carbonic Anhydrase IX;Journal of Nuclear Medicine;2024-03-21

2. Carbonic Anhydrase IX-Targeted α-Radionuclide Therapy with 225Ac Inhibits Tumor Growth in a Renal Cell Carcinoma Model;Pharmaceuticals;2022-05-02

3. Carbonic Anhydrase IX: A Renewed Target for Cancer Immunotherapy;Cancers;2022-03-09

4. Phase I study to assess safety, biodistribution and radiation dosimetry for 89Zr-girentuximab in patients with renal cell carcinoma;European Journal of Nuclear Medicine and Molecular Imaging;2021-03-02

5. Carbonic Anhydrase IX: Current and Emerging Therapies;Progress in Drug Research;2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3